Dapsone 100 Mg Tablet
NDC Package 83098-101-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Dapsone 100 Mg (dapsone tablets) tablets is a medication used to treat acne. This formulation utilizes a tablet delivery system. Marketed by Everest Life Sciences. Llc, this product is identified by NDC 83098-101 and is authorized under FDA application ANDA086842.

Identification & Billing

NDC Package Code
83098-101-01
Package Description
100 TABLET in 1 BOTTLE
Product Code
83098-101
11-Digit Billing Format
83098010101
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Dapsone 100 Mg
Non-Proprietary Name
Dapsone Tablets
Substance Name
Dapsone
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
DAPSONE 100 mg/1
Pharmacologic Class
Usage Information
This medication is used to treat acne. It helps decrease the number and severity of acne pimples and helps pimples that do develop to heal more quickly. Dapsone is an antibiotic. It is not known how dapsone works to treat acne.

Regulatory & Marketing

Labeler Name
Everest Life Sciences. Llc
Product Type
Human Prescription Drug
FDA Application #
ANDA086842
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-01-2024
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (83098-101). Click a package code to view its specific billing and regulatory data.

83098-101-03
30 TABLET in 1 BOTTLE

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 83098-101-01 identifies a specific commercial package of 100 tablet in 1 bottle of Dapsone 100 Mg, a human prescription drug labeled by Everest Life Sciences. Llc. This tablet is formulated for oral use and contains dapsone as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Everest Life Sciences. Llc on September 01, 2024. The current certification is valid through December 31, 2027.

What are the primary indications for this medication?

This medication is used to treat acne. It helps decrease the number and severity of acne pimples and helps pimples that do develop to heal more quickly. Dapsone is an antibiotic. It is not known how dapsone works to treat acne.

How is this Everest Life Sciences. Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 83098010101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
83098-101-01
11-Digit CMS (5-4-2)
83098-0101-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.